Pilgrim Partners Asia Pte LTD Repligen Corp Transaction History
Pilgrim Partners Asia Pte LTD
- $115 Billion
- Q4 2024
A detailed history of Pilgrim Partners Asia Pte LTD transactions in Repligen Corp stock. As of the latest transaction made, Pilgrim Partners Asia Pte LTD holds 380 shares of RGEN stock, worth $55,829. This represents 0.05% of its overall portfolio holdings.
Number of Shares
380Holding current value
$55,829% of portfolio
0.05%Shares
1 transactions
Others Institutions Holding RGEN
# of Institutions
479Shares Held
54.9MCall Options Held
297KPut Options Held
343K-
Black Rock Inc. New York, NY7.57MShares$1.11 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD7.14MShares$1.05 Billion0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.1MShares$749 Million0.01% of portfolio
-
State Street Corp Boston, MA1.69MShares$248 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.54MShares$227 Million1.48% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $8.15B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....